Science (American Association for the Advancement of Science), 2022-02, Vol.375 (6580), p.497-498
2022
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Lethal mutagenesis as an antiviral strategy
- Ist Teil von
- Science (American Association for the Advancement of Science), 2022-02, Vol.375 (6580), p.497-498
- Ort / Verlag
- United States: The American Association for the Advancement of Science
- Erscheinungsjahr
- 2022
- Quelle
- Science Online_科学在线
- Beschreibungen/Notizen
- [Figure: see text].
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0036-8075eISSN: 1095-9203DOI: 10.1126/science.abn0048Titel-ID: cdi_proquest_miscellaneous_2626005990
- Format
- –
- Schlagworte
- Animals, Antiviral agents, Antiviral Agents - adverse effects, Antiviral Agents - pharmacology, Antiviral Agents - therapeutic use, Coronaviruses, COVID-19 - drug therapy, COVID-19 - virology, Cytidine - adverse effects, Cytidine - analogs & derivatives, Cytidine - metabolism, Cytidine - pharmacology, Cytidine - therapeutic use, Cytidine - toxicity, DNA - biosynthesis, Epidemics, Evolution, Molecular, Genome, Viral, Humans, Hydroxylamines - adverse effects, Hydroxylamines - metabolism, Hydroxylamines - pharmacology, Hydroxylamines - therapeutic use, Mutagenesis, Mutagenicity Tests, Mutation, Phosphorylation, Ribavirin, Ribonucleosides - metabolism, RNA Virus Infections - drug therapy, RNA Virus Infections - virology, RNA viruses, RNA Viruses - drug effects, RNA Viruses - genetics, RNA, Viral - biosynthesis, RNA, Viral - genetics, SARS-CoV-2 - drug effects, SARS-CoV-2 - genetics, Severe acute respiratory syndrome, Severe acute respiratory syndrome coronavirus 2, Species extinction, Vector-borne diseases, Viral diseases, Viruses